Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
Cao X, Li B, Chen J, Dang J, Chen S, Gunes EG, Xu B, Tian L, Muend S, Raoof M, Querfeld C, Yu J, Rosen ST, Wang Y, Feng M.
Cao X, et al. Among authors: tian l.
J Immunother Cancer. 2021 Mar;9(3):e002022. doi: 10.1136/jitc-2020-002022.
J Immunother Cancer. 2021.
PMID: 33753567
Free PMC article.